Improving screening for major depressive disorder

被引:3
|
作者
Sharp, Lauren K. [1 ,4 ]
Montgomery, Susan L. [2 ]
Williams, Russell W. [3 ]
机构
[1] NextCare Urgent Care, Dumfries, VA USA
[2] Univ S Alabama, Coll Nursing, Community Mental Hlth Nursing, Mobile, AL USA
[3] Stafford Primary Care Associates, Stafford, VA USA
[4] 3990 Fettler Pk Dr, Dumfries, VA 22025 USA
关键词
Depression management; depression screening; primary care; quality improvement; PRIMARY-CARE; VALIDITY; ADULTS;
D O I
10.1097/JXX.0000000000000817
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background:Depression affects up to 20% of primary care patients and negatively affects patients' mental and physical health.Local Problem:At a primary care clinic, a review of 291 patient records revealed that no patients were being screened for depression using a validated and reliable tool.Methods:The problem was addressed through the implementation of a depression screening and management protocol based on the U.S. Preventive Services Task Force guidelines. Processes used were recommended by the American College of Preventive Medicine and Institute for Clinical Systems Improvement.Interventions:This project implemented a protocol to screen, treat, and manage patients with depression at this primary care clinic. Analysis compared preimplementation and postimplementation metrics, including the number of patients screened for depression, newly diagnosed with depression, offered antidepressants, offered referral, and managed with follow-up.Results:Implementing a depression screening and management protocol in this clinic significantly increased depression screenings, the percent of patients newly diagnosed with depression, and the number of patients offered treatment.Conclusion:This quality improvement (QI) project improved screening, diagnosis, and management of patients with depression in this primary care clinic. A future QI project for this clinic should focus on measures to track improvements in patients with depression at this primary care clinic.
引用
收藏
页码:71 / 78
页数:8
相关论文
共 50 条
  • [41] MicroRNAs in Major Depressive Disorder
    Fries, Gabriel R.
    Zhang, Wei
    Benevenuto, Deborah
    Quevedo, Joao
    REVIEWS ON BIOMARKER STUDIES IN PSYCHIATRIC AND NEURODEGENERATIVE DISORDERS, 2019, 1118 : 175 - 190
  • [42] Hyperthermia for Major Depressive Disorder?
    Fink, Max
    Shorter, Edward
    JAMA PSYCHIATRY, 2016, 73 (10) : 1096 - 1096
  • [43] SITUATIONAL MAJOR DEPRESSIVE DISORDER
    HIRSCHFELD, RMA
    KLERMAN, GL
    ANDREASEN, NC
    CLAYTON, PJ
    KELLER, MB
    ARCHIVES OF GENERAL PSYCHIATRY, 1985, 42 (11) : 1109 - 1114
  • [44] MANAGING MAJOR DEPRESSIVE DISORDER
    COHEN, LJ
    FORMULARY, 1995, 30 : S2 - S2
  • [45] The Mistreatment of Major Depressive Disorder
    Paris, Joel
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2014, 59 (03): : 148 - 151
  • [46] Temperament and major depressive disorder
    Elie G Karam
    Mariana M Salamoun
    Joumana S Yeretzian
    Zeina Mneimneh
    Aimee N Karam
    John Fayyad
    Annals of General Psychiatry, 9 (Suppl 1)
  • [47] Impairment in Major Depressive Disorder
    Pitchot, W
    Demyttenaere, K
    Albert, A
    Zhang, L
    De Cock, P
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S247 - S247
  • [48] Polypharmacy in major depressive disorder
    Touloumis, C.
    Ntounas, P.
    Tsopelos, C.
    Pappas, D.
    Mokas, C.
    Vasiliou, A.
    Chronopoulou, M.
    Dimitraka, M.
    Gogolakis, I.
    Marmarinou, C.
    Douzenis, A.
    Paraskevopoulou, A.
    Chatzimanolis, P.
    Stamou, S.
    Dimaki, S.
    Dimitriadis, D.
    Siouti, E.
    Konsta, A.
    Rizos, E.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 156 - 156
  • [49] VilazodoneIn Major Depressive Disorder
    James E. Frampton
    CNS Drugs, 2011, 25 : 615 - 627
  • [50] AripiprazoleIn Major Depressive Disorder
    Juliane Weber
    Katherine A. Lyseng-Williamson
    Lesley J. Scott
    CNS Drugs, 2008, 22 : 807 - 813